Federation des caisses Desjardins du Quebec »

Celldex Therapeutics shares owned by Federation des caisses Desjardins du Quebec

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Federation des caisses Desjardins du Quebec from 13F filings

Historical chart of Federation des caisses Desjardins du Quebec investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Federation des caisses Desjardins du Quebec consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Federation des caisses Desjardins du Quebec

Quarter filed Position value Share count Share price at filing
2024-03-31 $64k 1.5k 41.97

More positions owned by Federation des caisses Desjardins du Quebec

Microsoft Corp Common Stock (MSFT)
Banque Toronto-dominion Common Stock (TD)
Royal Bank Cda Common Stock (RY)
Vanguard 500 Indx Etf- Exchange Traded Fund Share (VOO)
Banque De Nouvelle-ecosse Common Stock (BNS)
Brookfield Corp Cl-a Lvs Common Stock (BN)
Sun Life Financial Common Stock (SLF)
Apple Common Stock (AAPL)
Telus Corp Common Stock (TU)
Bank Of Montreal Common Stock (BMO)
Alphabet A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Nvidia Common Stock (NVDA)
Berkshire Hathaway-b- Common Stock (BRK.B)
Cdn Natl Railway Common Stock (CNI)

View all positions for Federation des caisses Desjardins du Quebec

Top funds holding Celldex Therapeutics

FMR
Wellington Management Company
BlackRock
Vanguard Group
Eventide Asset Management
T. Rowe Price Associates
Kynam Capital Management
Bellevue Group
Pictet Asset Management Holding SA
Geode Capital Management
Rock Springs Capital Management
Point72 Asset Management
Marshall Wace
Redmile Group
Commodore Capital

View all funds holding Celldex Therapeutics